{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:09:54Z","timestamp":1762114194395,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K16238"],"award-info":[{"award-number":["21K16238"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010728","name":"Asahikawa Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cca.2023.117590","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T07:08:58Z","timestamp":1697094538000},"page":"117590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Monitoring mutant KRAS in plasma cell-free DNA can predict disease progression in a patient with multiple myeloma: A case report"],"prefix":"10.1016","volume":"551","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2001-199X","authenticated-orcid":false,"given":"Masayo","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumichi","family":"Toki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Hatayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatsu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117590_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cca.2019.12.026","article-title":"Emerging biomarkers in Multiple Myeloma: A review","volume":"503","author":"Gupta","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2023.117590_b0010","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cca.2023.117590_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2020.101146","article-title":"Tracking myeloma tumor DNA in peripheral blood","volume":"33","author":"Waldschmidt","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.cca.2023.117590_b0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2023.117590_b0025","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1182\/bloodadvances.2020002827","article-title":"A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma","volume":"4","author":"Munshi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.cca.2023.117590_b0030","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1158\/1078-0432.CCR-16-0866","article-title":"New developments in diagnosis, prognosis, and assessment of response in multiple myeloma","volume":"22","author":"Landgren","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2023.117590_b0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrclinonc.2014.239","article-title":"Minimal residual disease in multiple myeloma: bringing the bench to the bedside","volume":"12","author":"Mailankody","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cca.2023.117590_b0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jmoldx.2018.07.006","article-title":"Noninvasive molecular monitoring in multiple myeloma patients using cell-free tumor DNA","volume":"20","author":"Biancon","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.cca.2023.117590_b0045","doi-asserted-by":"crossref","first-page":"15086","DOI":"10.1038\/ncomms15086","article-title":"Circulating tumor DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates","volume":"8","author":"Kis","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2023.117590_b0050","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/1878-0261.12110","article-title":"An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving \u2018subsampling\u2019 issues","volume":"11","author":"Ono","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cca.2023.117590_b0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41379-019-0405-7","article-title":"Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection","volume":"33","author":"Nagai","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cca.2023.117590_b0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00535-020-01724-5","article-title":"Digital PCR-based plasma cell-free DNA mutation analysis for early-stage pancreatic tumor diagnosis and surveillance","volume":"55","author":"Okada","year":"2020","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cca.2023.117590_b0065","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2018.10.029","article-title":"Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features","volume":"156","author":"Omori","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2023.117590_b0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/bmt.2016.222","article-title":"Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis","volume":"51","author":"Landgren","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cca.2023.117590_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cyto.b.21273","article-title":"Better therapy requires better response evaluation: paving the way for minimal residual disease testing for every myeloma patient","volume":"90B","author":"Landgren","year":"2016","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.cca.2023.117590_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5644\/ama2006-124.242","article-title":"Multiple myeloma genomics \u2013 a concise review","volume":"48","author":"Castaneda","year":"2019","journal-title":"Acta Medica Academica."},{"key":"10.1016\/j.cca.2023.117590_b0085","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3324\/haematol.2017.163766","article-title":"The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma","volume":"102","author":"Mikulasova","year":"2017","journal-title":"Haematol."},{"key":"10.1016\/j.cca.2023.117590_b0090","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.20.00437","article-title":"Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression","volume":"38","author":"Bustoros","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2023.117590_b0095","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/clinchem\/hvab187","article-title":"Mutliple myeloma minimal residual disease detection: targeted mass spectrometry in blood vs next-generation sequencing in bone marrow","volume":"67","author":"Langerhorst","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2023.117590_b0100","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/bloodadvances.2018025197","article-title":"Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow","volume":"21","author":"Mazzotti","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.cca.2023.117590_b0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.seminhematol.2018.03.002","article-title":"Circulating tumor DNA for detecting minimal residual disease in multiple myeloma","volume":"55","author":"Pugh","year":"2018","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cca.2023.117590_b0110","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/cancers14051310","article-title":"The minimal residual disease using liquid biopsies in hematological malignancies","volume":"14","author":"Colmenares","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2023.117590_b0115","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3324\/haematol.2016.160564","article-title":"Monitoring multiple myeloma by quantification of recurrent mutations in serum","volume":"102","author":"Rustad","year":"2017","journal-title":"Haematolgica."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:06:02Z","timestamp":1762113962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123003923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":23,"alternative-id":["S0009898123003923"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117590","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring mutant KRAS in plasma cell-free DNA can predict disease progression in a patient with multiple myeloma: A case report","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117590"}}